Boucher HW - Search Results

1

Perspectives on Daptomycin resistance, with emphasis on resistance in Staphylococcus aureus.

Boucher HW, Sakoulas G. Boucher HW, et al. Clin Infect Dis. 2007 Sep 1;45(5):601-8. doi: 10.1086/520655. Epub 2007 Aug 1. Clin Infect Dis. 2007. PMID: 17682996 Review.

2

Clinical implications of stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: a study of 69 patients at 2 university hospitals.

Tsiodras S, Pittet D, Carmeli Y, Eliopoulos G, Boucher H, Harbarth S. Tsiodras S, et al. Scand J Infect Dis. 2000;32(6):651-6. doi: 10.1080/003655400459577. Scand J Infect Dis. 2000. PMID: 11200376

3

Chloramphenicol treatment for vancomycin-resistant Enterococcus faecium bacteremia.

Ricaurte JC, Boucher HW, Turett GS, Moellering RC, Labombardi VJ, Kislak JW. Ricaurte JC, et al. Among authors: boucher hw. Clin Microbiol Infect. 2001 Jan;7(1):17-21. doi: 10.1046/j.1469-0691.2001.00189.x. Clin Microbiol Infect. 2001. PMID: 11284938 Free article.

4

New agents for Staphylococcus aureus endocarditis.

Drees M, Boucher H. Drees M, et al. Curr Opin Infect Dis. 2006 Dec;19(6):544-50. doi: 10.1097/QCO.0b013e328010683e. Curr Opin Infect Dis. 2006. PMID: 17075329 Review.

5

Outcomes with daptomycin versus standard therapy for osteoarticular infections associated with Staphylococcus aureus bacteraemia.

Lalani T, Boucher HW, Cosgrove SE, Fowler VG, Kanafani ZA, Vigliani GA, Campion M, Abrutyn E, Levine DP, Price CS, Rehm SJ, Corey GR, Karchmer AW; S. aureus Endocarditis and Bacteraemia Study Group. Lalani T, et al. Among authors: boucher hw. J Antimicrob Chemother. 2008 Jan;61(1):177-82. doi: 10.1093/jac/dkm437. Epub 2007 Nov 13. J Antimicrob Chemother. 2008. PMID: 17999973 Clinical Trial.

6

Epidemiology of methicillin-resistant Staphylococcus aureus.

Boucher HW, Corey GR. Boucher HW, et al. Clin Infect Dis. 2008 Jun 1;46 Suppl 5:S344-9. doi: 10.1086/533590. Clin Infect Dis. 2008. PMID: 18462089 Review.

7

Associations between the genotypes of Staphylococcus aureus bloodstream isolates and clinical characteristics and outcomes of bacteremic patients.

Lalani T, Federspiel JJ, Boucher HW, Rude TH, Bae IG, Rybak MJ, Tonthat GT, Corey GR, Stryjewski ME, Sakoulas G, Chu VH, Alder J, Steenbergen JN, Luperchio SA, Campion M, Woods CW, Fowler VG. Lalani T, et al. Among authors: boucher hw. J Clin Microbiol. 2008 Sep;46(9):2890-6. doi: 10.1128/JCM.00905-08. Epub 2008 Jul 2. J Clin Microbiol. 2008. PMID: 18596141 Free PMC article.

8

Immunocompromised hosts: perspectives in the treatment and prophylaxis of cytomegalovirus disease in solid-organ transplant recipients.

Torres-Madriz G, Boucher HW. Torres-Madriz G, et al. Among authors: boucher hw. Clin Infect Dis. 2008 Sep 1;47(5):702-11. doi: 10.1086/590934. Clin Infect Dis. 2008. PMID: 18652557 Review.

9

Is it possible to blind a trial for community-acquired pneumonia?

Boucher HW. Boucher HW. Clin Infect Dis. 2008 Dec 1;47 Suppl 3:S210-5. doi: 10.1086/591428. Clin Infect Dis. 2008. PMID: 18986292 Review.

10

Position paper: recommended design features of future clinical trials of antibacterial agents for community-acquired pneumonia.

Spellberg B, Talbot GH, Brass EP, Bradley JS, Boucher HW, Gilbert DN; Infectious Diseases Society of America. Spellberg B, et al. Among authors: boucher hw. Clin Infect Dis. 2008 Dec 1;47 Suppl 3(Suppl 3):S249-65. Clin Infect Dis. 2008. PMID: 19018610 Free PMC article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

106 results

Search Page